APA (7th ed.) Citation

Saple, D. G., Save, S., Kumar, D., & Sood, S. (2022). An open label, single arm, pilot study to evaluate the safety, tolerability, and efficacy of daily fluconazole 150 mg in subjects suffering from Tinea cruris and Tinea corporis [version 1; peer review: Awaiting peer review]. F1000 research, 11, 1446. https://doi.org/10.12688/f1000research.127138.1

Chicago Style (17th ed.) Citation

Saple, Dattatray Gopal, Sushrut Save, Devesh Kumar, and Suneet Sood. "An Open Label, Single Arm, Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of Daily Fluconazole 150 Mg in Subjects Suffering from Tinea Cruris and Tinea Corporis [version 1; Peer Review: Awaiting Peer Review]." F1000 Research 11 (2022): 1446. https://doi.org/10.12688/f1000research.127138.1.

MLA (9th ed.) Citation

Saple, Dattatray Gopal, et al. "An Open Label, Single Arm, Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of Daily Fluconazole 150 Mg in Subjects Suffering from Tinea Cruris and Tinea Corporis [version 1; Peer Review: Awaiting Peer Review]." F1000 Research, vol. 11, 2022, p. 1446, https://doi.org/10.12688/f1000research.127138.1.